Treatment of locally advanced head and neck cancer: historical and critical review
- PMID: 12410178
- DOI: 10.1177/107327480200900504
Treatment of locally advanced head and neck cancer: historical and critical review
Abstract
Background: Advanced squamous cell cancers of the head and neck have traditionally been associated with high rates of morbidity and mortality. Advances in management have improved outcomes for most of these patients.
Methods: The author reviews the historical progress in management of these difficult tumors and adds his own wide experience to describe and evaluate newer approaches to management.
Results: Over the last 10 years, overall survival rates for patients with head and neck cancers have improved as has quality of life. New standards of care have been defined for patients with nasopharyngeal cancer and for those with advanced unresectable disease. Organ preservation is more commonly achieved.
Conclusions: Newer targeted therapies are likely to add to the progress that has already been achieved in the multimodality management of patients with head and neck cancers.
Similar articles
-
Locally advanced head and neck cancer.Curr Treat Options Oncol. 2001 Feb;2(1):7-13. doi: 10.1007/s11864-001-0012-x. Curr Treat Options Oncol. 2001. PMID: 12057136 Review.
-
A comparison of treatment outcomes by radiochemotherapy and postoperative radiotherapy in locally advanced squamous cell carcinomas of head and neck.Am J Clin Oncol. 2008 Aug;31(4):379-83. doi: 10.1097/COC.0b013e318165c036. Am J Clin Oncol. 2008. PMID: 18845998
-
Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.J Clin Oncol. 2004 Aug 1;22(15):3061-9. doi: 10.1200/JCO.2004.01.108. J Clin Oncol. 2004. PMID: 15284256 Clinical Trial.
-
Multidisciplinary Symposium on Head and Neck Cancer. 2 December 2005, Philadelphia, PA, USA.Expert Opin Pharmacother. 2006 Mar;7(4):489-94. doi: 10.1517/14656566.7.4.489. Expert Opin Pharmacother. 2006. PMID: 16503821
-
Molecular targeted therapies in all histologies of head and neck cancers: an update.Curr Opin Oncol. 2010 May;22(3):212-20. doi: 10.1097/CCO.0b013e328338001f. Curr Opin Oncol. 2010. PMID: 20173639 Review.
Cited by
-
Treatment outcome of cisplatin-based concurrent chemoradiotherapy in the patients with locally advanced nasopharyngeal cancer.Cancer Res Treat. 2008 Jun;40(2):62-70. doi: 10.4143/crt.2008.40.2.62. Epub 2008 Jun 30. Cancer Res Treat. 2008. PMID: 19688050 Free PMC article.
-
Acceptability of a Rinse Screening Test for Diagnosing Head and Neck Squamous Cell Carcinoma Among Black Americans.J Racial Ethn Health Disparities. 2015 Mar;2(1):62-7. doi: 10.1007/s40615-014-0048-9. Epub 2014 Sep 11. J Racial Ethn Health Disparities. 2015. PMID: 26863242
-
Nanosomal Docetaxel Lipid Suspension: A Guide to Its Use in Cancer.Clin Drug Investig. 2017 Apr;37(4):405-410. doi: 10.1007/s40261-017-0510-7. Clin Drug Investig. 2017. PMID: 28255844
-
Understanding molecular markers in recurrent oral squamous cell carcinoma treated with chemoradiation.Heliyon. 2016 Dec 5;2(12):e00206. doi: 10.1016/j.heliyon.2016.e00206. eCollection 2016 Dec. Heliyon. 2016. PMID: 27981249 Free PMC article.
-
Feasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative Review.Cancers (Basel). 2015 Aug 28;7(3):1716-42. doi: 10.3390/cancers7030858. Cancers (Basel). 2015. PMID: 26343729 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical